Esophageal Cancer Clinical Trials in Xi'an, Shannxi
2 recruitingXi'an, Shannxi, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study
Esophageal Cancer
Tang-Du Hospital80 enrolled1 locationNCT06663059
Recruiting
Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)
Esophageal Cancer
Fudan University385 enrolled11 locationsNCT05443841